Search results

Showing 222 to 224 of 224 search results for appointed representatives in the general insurance.

222. General Insurance pricing practices market study

     We have published the final findings of our general insurance pricing practices market study. As part of this, we set out a package of remedies to address the concerns identified.

223. General insurance product value and coronavirus (Covid-19) Guidance – update

     Studies and reviews Multi-firm reviews Published: 25/08/2021 Last modified: 25/08/2021
     We set out the findings from our multi-firm review assessing how firms have responded to our general insurance (GI) distribution chain Guidance (further to the product governance rules implemented by the IDD) and coronavirus (Covid-19) value Guidance

224. Ex post Impact Evaluation Framework – Feedback Statement

     Feedback statements Published: 20/12/2018 Last modified: 20/12/2018
     This feedback statement summarises views received from our stakeholders after the publication of a discussion paper in April 2018, and our responses to them.

225. PS15/21: Changes to the Approved Persons Regime for Solvency II firms: Final rules (including feedback on CP14/25, CP15/5 and CP15/16), and consequentials relating to CP15/22 on strengthening accountability in banking

     Policy statements Published: 13/08/2015 Last modified: 09/12/2016
     All firms to whom the PRA have applied the Solvency II regime, including Insurance Special Purpose Vehicles (ISPVs), the Society of Lloyd’s, managing agents and UK branches of foreign firms ... It is unlikely to be of practical relevance to approved